cognitive cybersecurity intelligence
The patent for REMODULIN (treprostinil), held by United Therap, has a widespread expiration date set for December 16, 2024. More information can be obtained from DrugPatentWatch.
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Register Now Panelists: Rodolphe Barrangou, PhD North Carolina State University View Bio Panelist Rodolphe Barrangou, PhD Rodolphe Barrangou, PhD, is the T. R. Klaenhammer Distinguished
Emerging Cybersecurity Threats: Safeguarding Your Organization in a Rapidly Evolving Landscape JD Supra
IDS: How To Identify & Mitigate Cybersecurity Risks at Your Dealership RV PRO
An Iran-nexus threat actor is suspected to be behind a password-spraying campaign targeting Microsoft 365 environments in Israel and the U.A.E. amid ongoing conflict in the Middle East.
